NI
MJN

Nuance Investments’s Mead Johnson Nutrition Company MJN Stock Holding History

Nuance Investments’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-761,961
Closed -$67.9M – 92
2017
Q1 		$67.9M Buy
+761,961
New +$62.7M 5.32% 4

Other funds holding MJN

PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
FNBOO
First National Bank of Omaha Omaha, Nebraska $3.24B AUM 18.68% 1-Year Est. Return
LFAS
Level Four Advisory Services Dallas, Texas $3.05B AUM 23.96% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return
WEC
Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return

Nuance Investments's MJN Position: Q2 2017 in Review

Nuance Investments sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 761,961 shares — an estimated $67.9M sold.

Nuance Investments first reported a position in MJN in Q1 2017 and held it in 1 quarter. The position peaked at $67.9M in Q1 2017. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Nuance Investments reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Nuance Investments sold 761,961 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $67.9M.
  • Nuance Investments first reported a position in Mead Johnson Nutrition Company in Q1 2017 and held it in 1 quarter.
  • Nuance Investments's Mead Johnson Nutrition Company position peaked at $67.9M in Q1 2017.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Nuance Investments's 13F filing for Q2 2017, filed 9 Aug 2017.